In view of the antioxidant roles of NRF2 and the potential implication of dexamethasone-induced ROS in the pathogenesis of insulin resistance and osteoporosis, we hypothesized that NRF2 might play a protective role against the deleterious effects of dexamethasone on metabolism and bone. Here, NFE2L2 is linked to Insulin resistance.